You searched for "macular"

2432 results found

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Retinoblastoma management update (part 2): treatment, screening and surveillance, long-term follow-up and new developments

Retinoblastoma treatment requires significant multidisciplinary input, but early detection through raising awareness remains key to improving outcomes. In the second article of a two-part series, Manoj Parulekar discusses retinoblastoma management, screening and research. This article has been published in two...

UKISCRS Cornea & Cataract Day 2026

United Kingdom & Ireland Society of Cataract & Refractce Surgeons Cornea & Cataract Day 2026

Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...

Demodex blepharitis: A transatlantic comparison of treatments available in the UK and US

Demodex blepharitis is widely recognised among eyecare professionals as an important cause of chronic lid margin inflammation, dry eye and ocular surface diseases. The characteristic feature for diagnosis is the presence of waxy deposit at the lash bases on slit...

HASA OPTIX Certifies as a B Corporation

Premium recyclable ophthalmic instrument company HASA OPTIX announces its certification as a B Corporation (B Corp) company. In a press release, the Brussels-based scale-up confirmed its score of 109.7 points on the B Impact Assessment, in which nonprofit B Lab...

BMLA 2023 Annual Conference & Educational Courses

Navroz Singh (far right) with Nirmal and Vasant Oswal (second and third left) and the other recipients of the Vasant and Nirmal Oswal Trainee Scholarship. Navroz Singh, core surgical trainee at Kings College NHS Trust. This year’s British Medical Laser...

BMLA Annual Conference & Educational Courses

Navroz Singh, core surgical trainee at Kings College NHS Trust. This year’s British Medical Laser Association (BMLA) annual conference was held over three days in a beautiful venue overlooking a sunny Cardiff Bay. It was attended by individuals hailing from...

Jun/Jul 2017 Quiz

History A 57-year-old female patient presented with gradual painless diplopia over the last six months. Examination revealed restricted upward eye movements and 4mm proptosis which did not increase with Valsalva manoeuvre. Intraocular pressure was normal, no visual defects were noted,...

Toxic nutritional optic neuropathy (TON)

Toxic optic neuropathy are a group of conditions manifested by reduction of visual functions secondary to damage to the anterior visual pathways from exposure to a toxin. The implicated toxin could be work-based, food or drink related, or iatrogenic medication....

Fundus photography in Malawi – setting up a screening programmefor diabetic retinopathy

We present the case of a 53-year-old lady who presented to the diabetes outpatient clinic at Kamuzu Central Hospital (KCH), Lilongwe, Malawi. She was diagnosed with type 2 diabetes mellitus six years ago, for which she takes metformin orally. She...

Triamcinolone (TA) deposits following subcutaneous injection to treat chalazion

Chalazia are chronic lipogranulomatous inflammations of the eyelid secondary to a blocked meibomian gland. Whilst most resolve spontaneously, certain chalazia warrant treatment. Options include incision and curettage (I&C), lesion excision, intralesional steroid injections, and botox injections [1]. I&C is usually...